ENDOCYTE INC's ticker is and the CUSIP is 29269A902. A total of 3 filers reported holding ENDOCYTE INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $49,000 | +25.6% | 15,700 | +61.9% | 0.00% | – |
| Q4 2015 | $39,000 | -23.5% | 9,700 | -13.4% | 0.00% | – |
| Q3 2015 | $51,000 | +24.4% | 11,200 | +41.8% | 0.00% | – |
| Q2 2015 | $41,000 | -43.8% | 7,900 | -32.5% | 0.00% | – |
| Q1 2015 | $73,000 | -12.0% | 11,700 | -11.4% | 0.00% | – |
| Q4 2014 | $83,000 | -58.7% | 13,200 | -60.1% | 0.00% | – |
| Q3 2014 | $201,000 | -2.4% | 33,100 | +6.1% | 0.00% | – |
| Q2 2014 | $206,000 | -83.3% | 31,200 | -39.7% | 0.00% | -100.0% |
| Q1 2014 | $1,231,000 | +811.9% | 51,700 | +310.3% | 0.00% | – |
| Q4 2013 | $135,000 | – | 12,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 152,400 | $927,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 159 | $97,000 | 0.00% |
| Citadel Advisors | 33,100 | $201,000 | 0.00% |